Tuesday, June 23, 2020
antiviral drug #Favipiravir
New antiviral drug #Favipiravir is launched with brand name FabiFlu from Glenmark for the treatment of mild to moderate Covid-19 patients.
A pack of 34 tablets of FabiFlu has been priced at Rs 3,500 (Rs 103 per tablet). The dosage is 200 mg X 9 tablets on day one and 200 mg X 4 tablets a day for 14 days of the treatment.
India’s Drug Regulator on Saturday gave permission to Hetero and Cipla to manufacture and market antiviral drug #Remdesivir for “restricted emergency use” on hospitalised COVID-19 patients.
Cipla and Hetero Labs have already entered into non-exclusive licensing agreements with US pharma giant Gilead Sciences, which is the patent holder of the drug remdesivir. It’s administered in the form of injection, should be given at a dose of 200 mg on day one followed by 100 mg daily for 5 days.
Written informed consent of each patient is required before the use of remdesivir.
Subscribe to:
Post Comments (Atom)
-
India is a country where a terrorist kept in jail for 10-15 year when he was main accused of killing more then 100 Indian Citizens where as ...
-
Coronavirus (COVID-19) Update: FDA Continues to Combat Fraudulent COVID-19 Medical Products Today, the U.S. Food and Drug Administrat...
-
It appears that the majority of people are getting cabin fever with the current pandemic. It’s similar to pulling of a bandaid excruciati...
No comments:
Post a Comment